|
|||||
|
|
Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity |
|
| Authors: | Kaitlin Anstett Robert Fusco Vincent Cutillas Thibault Mesplède Mark A. Wainberg |
| Affiliation: | aDepartment of Microbiology and Immunology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada;bMcGill AIDS Centre, Lady Davis Institute at the Jewish General Hospital, Montreal, Quebec, Canada |
| Abstract: | |
| Keywords: | |